Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Childhood Obesity and Insulin Resistance
NCT06266598Phase 4Completed
- Start
- Nov 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in childhood obesity, insulin resistance (IR). Started Nov 2019; status: completed.
02
Drugs
metformin
03
Conditions
childhood obesityinsulin resistance (IR)
Beyond the preview
Go deeper on NCT06266598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06266598.